|
|
|
|
|
|
|
|
medical news
June 21, 2016
...."This is potentially a very important discovery for women who carry a faulty BRCA1 gene, who have few other options. Current cancer prevention strategies for these women include surgical removal of the breasts and/or ovaries, which can have serious impacts on people's lives. To progress this work, denosumab would need to be formally tested in clinical trials in this setting as it is not approved for breast cancer prevention," Professor Lindeman said.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.